Scarica l'app Stockscreener
1.69
0.59%
-0.01
Cerus Corp Borsa (CERS) Ultime notizie
Cerus (NASDAQ:CERS) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
Greenman, Cerus Corp president, sells $156k in CERS stock By Investing.com - Investing.com Nigeria
Cerus CFO Kevin Green sells $169k in shares By Investing.com - Investing.com India
Cerus CFO Kevin Green sells $169k in shares - Investing.com
Cerus (NASDAQ:CERS) CFO Kevin Dennis Green Sells 55,225 Shares - MarketBeat
Cerus corp chief medical officer sells shares worth $250k By Investing.com - Investing.com South Africa
Cerus corp chief medical officer sells shares worth $250k - Investing.com
Cerus (CERS) CMO sells 125,894 shares, receives 55,220-share grant - Stock Titan
Cerus CFO Kevin Green sells $169k in CERS stock By Investing.com - Investing.com Australia
Cerus CFO Kevin Green sells $169k in CERS stock - Investing.com Australia
Cerus (NASDAQ:CERS) CFO Kevin Dennis Green Sells 27,796 Shares - MarketBeat
Richard Benjamin Sells 61,233 Shares of Cerus (NASDAQ:CERS) Stock - MarketBeat
Cerus Corp chief medical officer sells shares worth $202k By Investing.com - Investing.com South Africa
Cerus (CERS) CFO mixes stock award with planned and tax-driven sales - Stock Titan
Cerus Corp chief medical officer sells shares worth $202k - Investing.com
Cerus Corp chief legal officer Jensen sells $61,859 in stock - Investing.com
Cerus Corp chief legal officer Jensen sells $61,859 in stock By Investing.com - Investing.com Nigeria
Cerus Corp COO Jayaraman sells $68k in shares By Investing.com - Investing.com Canada
Cerus Corp COO Jayaraman sells $68k in shares - Investing.com
Greenman, Cerus Corp president, sells $156k in CERS stock - Investing.com
CERUS (CERS) CEO gets 193k-share grant, sells 78k shares to cover tax withholding - Stock Titan
Richard J. Benjamin sells 61,233 and 24,235 CERS shares (NASDAQ: CERS) - Stock Titan
Cerus Details INTERCEPT Growth Plan, BCA Deal Upside and 2026 RBC Milestones at TD Cowen Conference - Yahoo Finance
Cerus (NASDAQ:CERS) Stock Rating Lowered by Wall Street Zen - MarketBeat
Cathie Wood's ARK Investment Acquires Shares in Cerus (CERS) - GuruFocus
Morgan Stanley files Form 144 listing CERS restricted-share notices (CERS) - Stock Titan
Cerus (CERS) awards 264,000 restricted stock units to its CMO - Stock Titan
CERS Earnings History & Surprises | EPS & Revenue Results | CERUS CORP (NASDAQ:CERS) - ChartMill
Cerus Corporation (NASDAQ:CERS) Q4 2025 Earnings Call Transcript - Insider Monkey
Cerus (CERS) Revenue Growth Outpaces Market And Reinforces Bullish Margin Recovery Narrative - simplywall.st
Cerus at TD Cowen Conference: Strategic Growth in Blood Transfusion - Investing.com South Africa
$CERS stock is down 16% today. Here's what we see in our data. - Quiver Quantitative
Cerus Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
MongoDB, Surgery Partners, Harrow And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Cerus Corp (CERS) Q4 2025 Earnings Call Highlights: Record Reven - GuruFocus
Cerus Corporation 2025 Annual Report: INTERCEPT Blood System, Product Pipeline, and Regulatory Updates - Minichart
Cerus: Q4 Earnings Snapshot - theheraldreview.com
Cerus Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Cerus Q4 Earnings Call Highlights - Yahoo Finance
Cerus Corp (NASDAQ:CERS) Reports Mixed Q4 2025 Results, Stock Falls on Revenue Miss - ChartMill
Cerus: Q4 Financial Results Overview - Bitget
Earnings call transcript: Cerus Corporation Q4 2025 exceeds revenue expectations - Investing.com
Cerus (NASDAQ:CERS) Posts Quarterly Earnings Results, Hits Expectations - MarketBeat
Cerus 10-K: Revenue $233.8M, product growth drives results - TradingView
Cerus (NASDAQ: CERS) outlines INTERCEPT blood system pipeline - Stock Titan
CERS Forecasts Growth in 2026 Product Revenue - GuruFocus
Cerus Corporation (CERS) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
Cerus falls 7% after posting in-line Q4 earnings, revenue beat - Investing.com South Africa
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Cerus Q4 Earnings Assessment - Benzinga
Cerus (Nasdaq: CERS) grows 2025 revenue 16% and reaffirms 2026 outlook - Stock Titan
Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results - Yahoo Finance
Cerus (CERS) Set to Release Q4 Earnings with Modest Revenue Grow - GuruFocus
CERS PE Ratio & Valuation, Is CERS Overvalued - Intellectia AI
Cerus (NASDAQ:CERS) Stock Price Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
0.66%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):